0001842952-22-000018.txt : 20220225
0001842952-22-000018.hdr.sgml : 20220225
20220225163836
ACCESSION NUMBER: 0001842952-22-000018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220225
FILED AS OF DATE: 20220225
DATE AS OF CHANGE: 20220225
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lehr Martin A.
CENTRAL INDEX KEY: 0001861989
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40654
FILM NUMBER: 22680908
MAIL ADDRESS:
STREET 1: 3675 MARKET STREET
STREET 2: SUITE 200
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Context Therapeutics Inc.
CENTRAL INDEX KEY: 0001842952
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 863738787
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3675 MARKET STREET
STREET 2: SUITE 200
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
BUSINESS PHONE: 267-225-7416
MAIL ADDRESS:
STREET 1: 3675 MARKET STREET
STREET 2: SUITE 200
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
FORMER COMPANY:
FORMER CONFORMED NAME: Context Therapeutics LLC
DATE OF NAME CHANGE: 20210128
4
1
wf-form4_164582507420064.xml
FORM 4
X0306
4
2022-02-25
0
0001842952
Context Therapeutics Inc.
CNTX
0001861989
Lehr Martin A.
2001 MARKET STREET
SUITE 3915, UNIT #15
PHILADELPHIA
PA
19103
1
1
0
0
Chief Executive Officer
Stock Option (right to buy)
1.79
2022-02-25
4
A
0
254300
0
A
2032-02-24
Common Stock
254300.0
254300
D
The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 25, 2023, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer.
/s/ Alex Levit, Attorney-in-Fact
2022-02-25